Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 050790

Expand all

RESTASIS (CYCLOSPORINE)
0.05% Marketing Status: Prescription

Active Ingredient: CYCLOSPORINE
Proprietary Name: RESTASIS
Dosage Form; Route of Administration: EMULSION; OPHTHALMIC
Strength: 0.05%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N050790
Product Number: 001
Approval Date: Dec 23, 2002
Applicant Holder Full Name: ALLERGAN INC
Marketing Status:  Prescription
Patent and Exclusivity Information

RESTASIS MULTIDOSE (CYCLOSPORINE)
0.05% Marketing Status: Prescription

Active Ingredient: CYCLOSPORINE
Proprietary Name: RESTASIS MULTIDOSE
Dosage Form; Route of Administration: EMULSION; OPHTHALMIC
Strength: 0.05%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N050790
Product Number: 002
Approval Date: Oct 27, 2016
Applicant Holder Full Name: ALLERGAN INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English